Lv3
288 积分 2023-11-09 加入
Ribociclib plus Endocrine Therapy in Early Breast Cancer
3小时前
已关闭
中国乳腺癌抗体药物偶联物安全性管理专家共识
7天前
已完结
Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates: A Review
15天前
已完结
Navigating the complexity of PI3K/AKT pathway in HER-2 negative breast cancer: biomarkers and beyond
1个月前
已完结
Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
1个月前
已完结
Ribociclib plus Endocrine Therapy in Early Breast Cancer
1个月前
已完结
Ribociclib plus Endocrine Therapy in Early Breast Cancer
1个月前
已完结
Safety and Tolerability of Concurrent Radiotherapy and Sacituzumab Govitecan in Metastatic Breast Cancer
1个月前
已完结
Radiation Therapy With Cyclin-Dependent Kinase 4/6 Inhibitors: A Multi-institutional Safety and Toxicity Study
1个月前
已完结
Feasibility and Tolerability of Adjuvant Capecitabine-Based Chemoradiation in Patients With Breast Cancer and Residual Disease After Neoadjuvant Chemotherapy: A Prospective Clinical Trial
1个月前
已完结
皖公网安备34019202002308
